alexa Lymphoma | Japan| PDF | PPT| Case Reports | Symptoms | Treatment

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Recommended Journals

Relevant Topics

Lymphoma

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
  • Lymphoma

    Lymphoma is a form of cancer that affects the immune system - specifically, it is a cancer of immune cells called lymphocytes, a type of white blood cell. There are two broad types of lymphoma and many subtypes.The two types of lymphoma are described as: Hodgkin's or non-Hodgkin's.Lymphoma can occur at any age but is the most common cancer in young people. It is often very treatable, and most people live for a long time after being diagnosed.Use this page for comprehensive and easy-to-follow information about lymphoma - both non-Hodgkin's and Hodgkin's lymphoma.
  • Lymphoma

    The symptoms typically involve painless swelling of the lymph nodes (glands), often in the neck or armpits where these nodes are concentrated. Swelling may also occur in the groin and abdomen, although some people do not experience any detectable swelling in any part of the body.You may be familiar with this sign because the lymph nodes in the neck (commonly referred to as "glands") can become swollen during infections such as the cold - but here the swelling subsides, whereas it does not in cancer
  • Lymphoma

    Treatment is usually effective and leads to a period of remission, where the patient is free from the disease Indolent (low-grade) lymphoma may relapse though, requiring further treatment. In some cases, an indolent lymphoma can become aggressive, which necessitates more aggressive treatment Typically people with indolent lymphoma live for a long time and have a good quality of life Some people may not require any treatment In contrast, patients diagnosed with a high-grade or intermediate lymphoma will typically require immediate and intensive treatment to help slow down tumor growth and, eventually, to shrink the tumor Where indolent lymphoma turns into aggressive lymphoma this can be especially difficult as the tumors may be widespread, whereas an aggressive lymphoma may be caught earlier and still be somewhat localized.
  • Lymphoma

    The overall five-year relative survival rate for leukemia has more than quadrupled since 1960. From 1960 to 1963, the five-year relative survival rate among whites (only data available) with leukemia was 14 percent. From 1975 to 1977, the five-year relative survival rate for the total population with leukemiawas 34.2 percent, and from 2004 to 2010, the overall relative survival rate was 60.3 percent.From 2004-2010, the five-year relative survival rates overall were CML - 59.9 percent CLL - 83.5 percent AML - 25.4 percent overall and 66.3 percent for children and adolescents younger than 15 years ALL - 70 percent overall, 91.8 percent for children and adolescents younger than 15 years, and 93 percent for children younger than 5 years.

Expert PPTs

Speaker PPTs

 

High Impact List of Articles

Conference Proceedings

International Conferences 2018-19

Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Conferences By Continents

USA & Americas

Asia-Pacific & Middle East

Europe

Medical & Clinical Conferences

Conferences by Subject

Contact Us

Agri and Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

Content of this site is vailable under  Creative Commons Attribution 4.0 License
Copyright © 2018 OMICS International All Rights Reserved.